Free Trial

Elanco Animal Health (ELAN) Competitors

Elanco Animal Health logo
$21.60 -0.05 (-0.21%)
As of 11:58 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

ELAN vs. ONC, INSM, BNTX, TEVA, GMAB, SMMT, ASND, RDY, VTRS, and ROIV

Should you be buying Elanco Animal Health stock or one of its competitors? The main competitors of Elanco Animal Health include BeOne Medicines (ONC), Insmed (INSM), BioNTech (BNTX), Teva Pharmaceutical Industries (TEVA), Genmab A/S (GMAB), Summit Therapeutics (SMMT), Ascendis Pharma A/S (ASND), Dr. Reddy's Laboratories (RDY), Viatris (VTRS), and Roivant Sciences (ROIV). These companies are all part of the "pharmaceutical products" industry.

Elanco Animal Health vs. Its Competitors

BeOne Medicines (NASDAQ:ONC) and Elanco Animal Health (NYSE:ELAN) are both large-cap medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, profitability, earnings, institutional ownership, risk, dividends and valuation.

Elanco Animal Health has a net margin of 9.68% compared to BeOne Medicines' net margin of -3.89%. Elanco Animal Health's return on equity of 7.04% beat BeOne Medicines' return on equity.

Company Net Margins Return on Equity Return on Assets
BeOne Medicines-3.89% -1.22% -0.72%
Elanco Animal Health 9.68%7.04%3.45%

48.5% of BeOne Medicines shares are held by institutional investors. Comparatively, 97.5% of Elanco Animal Health shares are held by institutional investors. 6.6% of BeOne Medicines shares are held by company insiders. Comparatively, 0.9% of Elanco Animal Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

BeOne Medicines has a beta of 0.31, suggesting that its stock price is 69% less volatile than the S&P 500. Comparatively, Elanco Animal Health has a beta of 1.65, suggesting that its stock price is 65% more volatile than the S&P 500.

Elanco Animal Health has lower revenue, but higher earnings than BeOne Medicines. BeOne Medicines is trading at a lower price-to-earnings ratio than Elanco Animal Health, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
BeOne Medicines$4.56B7.49-$644.79M-$1.73-180.10
Elanco Animal Health$4.44B2.42$338M$0.8625.11

BeOne Medicines currently has a consensus price target of $345.60, indicating a potential upside of 10.92%. Elanco Animal Health has a consensus price target of $20.00, indicating a potential downside of 7.39%. Given BeOne Medicines' higher probable upside, research analysts clearly believe BeOne Medicines is more favorable than Elanco Animal Health.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
BeOne Medicines
1 Sell rating(s)
0 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.90
Elanco Animal Health
0 Sell rating(s)
3 Hold rating(s)
6 Buy rating(s)
2 Strong Buy rating(s)
2.91

In the previous week, Elanco Animal Health had 3 more articles in the media than BeOne Medicines. MarketBeat recorded 12 mentions for Elanco Animal Health and 9 mentions for BeOne Medicines. BeOne Medicines' average media sentiment score of 0.99 beat Elanco Animal Health's score of 0.83 indicating that BeOne Medicines is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
BeOne Medicines
5 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Elanco Animal Health
6 Very Positive mention(s)
1 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Summary

Elanco Animal Health beats BeOne Medicines on 11 of the 17 factors compared between the two stocks.

Get Elanco Animal Health News Delivered to You Automatically

Sign up to receive the latest news and ratings for ELAN and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding ELAN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ELAN vs. The Competition

MetricElanco Animal HealthMED IndustryMedical SectorNYSE Exchange
Market Cap$10.72B$4.30B$6.17B$21.92B
Dividend YieldN/A1.24%5.72%3.62%
P/E Ratio25.1030.0929.5832.57
Price / Sales2.42251.10572.9281.90
Price / Cash9.5928.9537.1224.33
Price / Book1.754.7612.014.65
Net Income$338M$197.51M$3.33B$1.02B
7 Day Performance5.34%2.07%-0.41%1.16%
1 Month Performance16.35%4.30%5.79%0.14%
1 Year Performance72.62%29.06%65.67%12.52%

Elanco Animal Health Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ELAN
Elanco Animal Health
2.7271 of 5 stars
$21.60
-0.2%
$20.00
-7.4%
+70.9%$10.72B$4.44B25.109,000Analyst Forecast
ONC
BeOne Medicines
3.1459 of 5 stars
$327.03
+2.2%
$340.30
+4.1%
N/A$35.08B$4.56B-189.0311,000Analyst Forecast
INSM
Insmed
2.9508 of 5 stars
$163.94
+1.0%
$149.06
-9.1%
+117.7%$34.31B$363.71M-28.711,271Positive News
Upcoming Earnings
Analyst Forecast
BNTX
BioNTech
2.657 of 5 stars
$102.30
+0.2%
$134.32
+31.3%
-4.2%$24.54B$2.98B-63.946,772News Coverage
Analyst Forecast
TEVA
Teva Pharmaceutical Industries
3.6911 of 5 stars
$20.02
-0.1%
$25.57
+27.8%
+3.0%$22.97B$16.54B-125.0936,830Positive News
GMAB
Genmab A/S
3.8943 of 5 stars
$32.68
+2.7%
$40.80
+24.8%
+31.4%$20.42B$3.12B16.422,682Short Interest ↑
Analyst Revision
Gap Down
SMMT
Summit Therapeutics
2.8208 of 5 stars
$22.93
+7.4%
$31.29
+36.4%
-6.9%$15.86B$700K-22.70110Trending News
Earnings Report
Analyst Forecast
Options Volume
Analyst Revision
ASND
Ascendis Pharma A/S
2.9358 of 5 stars
$208.43
-0.5%
$248.29
+19.1%
+57.0%$12.93B$393.54M-40.391,017Gap Up
RDY
Dr. Reddy's Laboratories
2.9368 of 5 stars
$14.36
+0.1%
$16.95
+18.1%
-6.7%$11.97B$3.81B21.7527,811
VTRS
Viatris
3.0501 of 5 stars
$9.86
+1.2%
$10.40
+5.5%
-10.8%$11.36B$14.74B-3.4032,000Analyst Forecast
ROIV
Roivant Sciences
2.8895 of 5 stars
$16.21
+1.1%
$19.94
+23.0%
+53.1%$10.95B$29.05M-23.16860

Related Companies and Tools


This page (NYSE:ELAN) was last updated on 10/23/2025 by MarketBeat.com Staff
From Our Partners